Free Trial

ATI Physical Therapy (ATIP) Competitors

$4.76
-0.07 (-1.45%)
(As of 05/31/2024 ET)

ATIP vs. CMAX, BKD, HCSG, CMRX, MRNS, DTIL, PLX, BRNS, FORA, and IOBT

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include CareMax (CMAX), Brookdale Senior Living (BKD), Healthcare Services Group (HCSG), Chimerix (CMRX), Marinus Pharmaceuticals (MRNS), Precision BioSciences (DTIL), Protalix BioTherapeutics (PLX), Barinthus Biotherapeutics (BRNS), Forian (FORA), and IO Biotech (IOBT).

ATI Physical Therapy vs.

ATI Physical Therapy (NYSE:ATIP) and CareMax (NASDAQ:CMAX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations.

In the previous week, CareMax had 1 more articles in the media than ATI Physical Therapy. MarketBeat recorded 2 mentions for CareMax and 1 mentions for ATI Physical Therapy. CareMax's average media sentiment score of 1.43 beat ATI Physical Therapy's score of -1.00 indicating that CareMax is being referred to more favorably in the news media.

Company Overall Sentiment
ATI Physical Therapy Negative
CareMax Positive

CareMax has a consensus price target of $45.00, indicating a potential upside of 1,435.84%. Given CareMax's higher probable upside, analysts plainly believe CareMax is more favorable than ATI Physical Therapy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ATI Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
CareMax
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

ATI Physical Therapy has higher earnings, but lower revenue than CareMax. ATI Physical Therapy is trading at a lower price-to-earnings ratio than CareMax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ATI Physical Therapy$699.02M0.03-$69.79M-$28.92-0.16
CareMax$751.10M0.01-$683.35M-$172.36-0.02

ATI Physical Therapy received 6 more outperform votes than CareMax when rated by MarketBeat users. Likewise, 36.59% of users gave ATI Physical Therapy an outperform vote while only 30.00% of users gave CareMax an outperform vote.

CompanyUnderperformOutperform
ATI Physical TherapyOutperform Votes
15
36.59%
Underperform Votes
26
63.41%
CareMaxOutperform Votes
9
30.00%
Underperform Votes
21
70.00%

ATI Physical Therapy has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500. Comparatively, CareMax has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 65.9% of CareMax shares are held by institutional investors. 3.3% of ATI Physical Therapy shares are held by insiders. Comparatively, 26.9% of CareMax shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

ATI Physical Therapy has a net margin of -8.15% compared to CareMax's net margin of -79.55%. ATI Physical Therapy's return on equity of 0.00% beat CareMax's return on equity.

Company Net Margins Return on Equity Return on Assets
ATI Physical Therapy-8.15% N/A -5.04%
CareMax -79.55%-57.78%-20.64%

Summary

ATI Physical Therapy beats CareMax on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$20.94M$530.29M$5.13B$17.79B
Dividend YieldN/AN/A2.75%3.55%
P/E Ratio-0.1618.91167.1725.81
Price / Sales0.030.242,418.7811.40
Price / Cash0.804.8635.3018.95
Price / Book-0.181.895.535.90
Net Income-$69.79M-$225.94M$106.01M$976.46M
7 Day Performance-1.04%1.28%1.14%0.62%
1 Month Performance11.61%-4.34%1.43%4.79%
1 Year Performance-40.91%-14.77%4.07%24.00%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMAX
CareMax
3.3371 of 5 stars
$2.97
+2.8%
$45.00
+1,415.2%
-96.8%$11.29M$751.10M-0.021,450Short Interest ↓
Positive News
Gap Down
BKD
Brookdale Senior Living
3.0666 of 5 stars
$6.61
-1.3%
$7.50
+13.5%
+98.5%$1.28B$3.02B-8.5825,200Short Interest ↓
HCSG
Healthcare Services Group
2.5033 of 5 stars
$10.50
-2.1%
$14.50
+38.1%
-19.9%$773.33M$1.67B18.4233,400Positive News
CMRX
Chimerix
4.5136 of 5 stars
$0.94
+0.7%
$8.50
+801.9%
-30.4%$84.48M$41,000.00-1.0172Analyst Upgrade
Short Interest ↓
MRNS
Marinus Pharmaceuticals
4.3522 of 5 stars
$1.54
+2.3%
$13.79
+798.1%
-80.3%$84.32M$30.99M-0.58165Gap Down
DTIL
Precision BioSciences
3.9117 of 5 stars
$12.07
-4.6%
$46.33
+283.9%
-43.9%$83.65M$48.73M-1.62109Analyst Forecast
PLX
Protalix BioTherapeutics
2.591 of 5 stars
$1.13
-2.6%
$10.00
+785.0%
N/A$82.85M$65.49M28.25208Gap Down
BRNS
Barinthus Biotherapeutics
2.5995 of 5 stars
$2.11
-6.6%
$8.00
+279.1%
N/A$82.35M$800,000.00-1.15130Short Interest ↓
Positive News
Gap Down
FORA
Forian
3.3075 of 5 stars
$2.64
+0.8%
$7.67
+190.4%
+4.4%$82.21M$20.49M26.40102Positive News
IOBT
IO Biotech
2.7841 of 5 stars
$1.24
-3.9%
$9.67
+679.4%
-41.0%$81.70MN/A-0.6668Positive News

Related Companies and Tools

This page (NYSE:ATIP) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners